News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

07/20/2021 | Ovesco Endoscopy AG

BougieCap®: significant symptomatic improvement of esophageal strictures achieved by a single bougienage in patients with eosinophilic esophagitis

A cohort study of 50 patients with symptomatic eosinophilic esophagitis treated with a single dilation session using the BougieCap showed 100 % technical success, a drop ...
07/08/2021 | Ovesco Endoscopy AG

HemoPill® acute shows promising results in a non-fasting patient with a mid-gastrointestinal bleeding: a case report

Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal (GI) bleeding was successfully used in a patient with a bleeding caused by Mecke...
07/08/2021

With Codex4SMEs from researching biomarkers to entering the market

On July 6th 2021 the online event „Biomarkers from Research to Market“ took place as part of the Interreg NWE project Codex4SMEs. Close to 50 participants used the opportunity to receive a detailed in...
07/07/2021 | Immatics

BioCopy AG and Immatics enter into a collaboration to characterize T cell receptor – peptide-HLA interactions

T cell therapies open up promising therapeutic perspectives and are currently still limited to only a few specific areas of application. In the field of oncology, two the...

4 clusters talked about new potential in medicine

Developers, users and IT experts discussed current trends in point-of-care diagnostics, new materials and the use of artificial intelligence in medicine at an interdisciplinary online event. In addition to exciting presentations, the event offer...
06/30/2021 | CureVac AG

CureVac Announces Appointment of Dr. Malte Greune as Chief Operating Officer and Transition of Dr. Florian von der Mülbe to Lead Accelerated Development of The RNA Printer®

CureVac N.V. (Nasdaq: CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mR...
06/30/2021 | CureVac AG

CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60

Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy analysis; original strain almost ...
06/23/2021 | CureVac AG

CureVac Provides Supervisory Board Update

CureVac N.V. (Nasdaq: CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that Dr. Ingmar Hoerr, former Founding-CEO and former...
06/23/2021

Diagnostic Developers met Investors with Codex4SMEs

To give small and medium-sized companies the chance to quickly launch new products on the market, the Interreg NWE project Codex4SMEs supports SMEs to pitch to investors through the online event MeetM...
06/22/2021 | Universität Hohenheim

Advanced biofuel breakthrough: HyFlexFuel converted sewage sludge and other biomasses into kerosene by hydrothermal liquefaction (HTL)

The EU funded research project HyFlexFuel recently succeeded to produce biocrudes via hydrothermal liquefaction (HTL) from a variety of biomasses, including sewage sludge...
06/15/2021

Smart analytics: network meeting heralds the second phase

Since May 2020, the Central Innovation Program for SMEs (ZIM) of the Federal Ministry for Economic Affairs and Energy (BMWi) has been promoting the development of the international cooperation network...
06/11/2021

Air to live: Innovative ways to reduce the risk of contamination in buildings

The issue of indoor air quality has become enormously important in connection with the current pandemic situation. On June 9, 2021, BioRegio STERN Management GmbH therefo...
06/02/2021 | Ovesco Endoscopy AG

Preliminary results from RCT study show that OTSC first-line treatment is superior to standard treatment for acute non-varicose upper GI bleeding with high risk of rebleeding

In this week's news you can find the summary of the presentation on the STING II study by Prof. K. Caca, Ludwigsburg at the DGE-BV 2021. To read the news in German please...
06/01/2021 | Computomics GmbH

Beck's Advances Breeding Program Through Continued Partnership with Computomics

Beck's, the largest family-owned retail seed company in the United States, is proud to expand their collaboration with Computomics, a biotechnology company in Tübingen, G...
05/28/2021 | CureVac AG

CureVac’s First-Generation COVID-19 Vaccine Candidate, CVnCoV, Continues Toward Phase 2b/3 Efficacy Readout in Variant-rich Environment Following DSMB Recommendation

Study continues to progress according to protocol following first interim analysis at 59 eligible COVID-19 cases Sequencing data to be made available in parallel wit...
05/26/2021 | CureVac AG

CureVac Announces Financial Results for the First Quarter of 2021 and Business Updates

First-Generation COVID-19 vaccine program, CVnCoV Phase 3 trial started with CVnCoV in adults suffering from selected comorbidities Phase 2a trial in Peru and...
05/26/2021 | Immatics

Immatics Announces Changes to its Board of Directors

Tuebingen, Germany and Houston, Texas, May 26, 2021 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting...
05/21/2021

Codex4SMEs expert group with Biobank Graz

On May 17th, 2021, the Interreg NWE project Codex4SMEs invited to an online expert panel with Biobank Graz. ...